Two-day virtual meeting brought together stakeholders from academia, government, and industry to discuss challenges related to antimicrobial stewardship during the COVID-19 pandemic.

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.

New guidance from the U.S. Department of Health and Human Services adds licensed pharmacists as “covered persons” under the Public Readiness and Emergency Preparedness (PREP) Act.

Guide published by the Peter Lamy Center on Drug Therapy and Aging and US Deprescribing Research Network offers recommendations to improve resident-centered health and reduce opportunities for transmission of COVID-19 in post-acute and long-term care facilities.

Faculty, staff, students, trainees, and alumni share stories about how they are stepping up to assist family, friends, colleagues, and their communities during the COVID-19 pandemic.